Registered small business
NANOLIT LIMITED LIABILITY COMPANY
LITTLE ROCK, AR · Established 2026
Capabilities
Nanoparticle based chemotherapeutic drug is developed to address the side effect of existing FDA approved Doxorubicin drug. Our nanomedicine exhibit enhanced toxicity and selectivity towards cancer cells only.
Federal performance
- Awards
- —
- Obligated
- —
- Agencies served
- —
Registered NAICS codes
Select a code to copy it.
Other designations
Self-certified: WOSB